Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference

Thanh Thanh Nguyen Phan,Matthew G Hvasta,Devina J Thiono,Ruby Parimal Shah,Gisselle P Ajo,Wei-chiao Huang,Jonathan Lovell,Shaomin Tian,Aravinda M de Silva,Brian Kuhlman

DOI: https://doi.org/10.1101/2024.08.20.608851

2024-08-20

Abstract:The four serotypes of dengue virus (DENV1-4) are a major health concern putting 50% of the global population at risk of infection. Crucially, DENV vaccines must be tetravalent to provide protection against all four serotypes because immunity to only one serotype can enhance infections caused by heterologous serotypes. Uneven replication of live-attenuated viruses in tetravalent vaccines can lead to disease enhancement instead of protection. Subunit vaccines are a promising alternative as the vaccine components are not dependent on viral replication and antigen doses can be controlled to achieve a balanced response. Here, we show that a tetravalent subunit vaccine of dengue envelope (E) proteins computationally stabilized to form native-like dimers elicits type-specific neutralizing antibodies in mice against all four serotypes. The immune response was enhanced by displaying the E dimers on liposomes embedded with adjuvant, and no interference was detected between the four components.

Microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a tetravalent vaccine that can effectively prevent infection by all four serotypes of the dengue virus (DENV). Specifically, the researchers focused on how to induce mice to produce specific neutralizing antibodies against all four serotypes through the combination of stabilized dengue virus envelope protein (E - protein) dimers and liposomes, while avoiding immune interference (i.e., the weakening of the immune response or disease enhancement caused by cross - reactions between different serotypes).

### Research Background
There are four serotypes of the dengue virus (DENV1 - 4), and about half of the global population is at risk of infection. Traditional tetravalent vaccines (such as live - attenuated vaccines) have safety issues because they may lead to unbalanced immune responses, thereby increasing the risk of infection by certain serotypes. Therefore, the researchers turned to subunit vaccines. This type of vaccine does not rely on virus replication and can achieve a balanced immune response by controlling the antigen dose.

### Research Methods
1. **Stabilization of E - protein**: The researchers designed a series of mutations by computational methods, enabling the E - protein to form stable dimers under physiological conditions and increasing the expression level and thermal stability.
2. **Liposome platform**: Cobalt porphyrin phospholipid (CoPoP) liposomes were used as an antigen - presenting platform, and immune - stimulating adjuvants (such as PHAD - 3D6A and QS - 21) were simultaneously embedded to enhance the immune response.
3. **Animal experiments**: The immunogenicity and neutralizing activity of monovalent, bivalent, and tetravalent vaccines were evaluated through mouse experiments, especially to detect the presence of immune interference.

### Main Findings
- **Stability of E - protein dimers**: The mutated E - protein dimers remained stable at low concentrations and could effectively bind to known neutralizing antibodies.
- **Effect of liposome presentation**: Presenting E - protein dimers on CoPoP liposomes significantly enhanced antibody production and neutralizing activity.
- **No immune interference**: The tetravalent vaccine formulation could induce specific neutralizing antibodies against all four serotypes, and no immune interference between different serotypes was observed.
- **Source of neutralizing activity**: Through antibody depletion experiments, it was confirmed that the neutralizing activity mainly came from specific antibodies against each serotype, rather than cross - reactive antibodies.

### Conclusion
The research results show that the tetravalent subunit vaccine using stabilized E - protein dimers combined with CoPoP liposomes can induce potent specific neutralizing antibodies against all four dengue virus serotypes in mice without causing immune interference. This finding provides a new direction for the development of safe and effective dengue vaccines.